Early research (Phase 1)Study completedNCT03197623
What this trial is testing
Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids
Who this might be right for
OsteopeniaOsteoporosisOsteonecrosis
Nancy E. Lane, MD 58